Skip to main content
Erschienen in:

11.08.2023 | Observational Research

Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients

verfasst von: Sylvain Mathieu, C. Lambert, Françoise Fayet, Marion Couderc, Marine Beauger, Sandrine Malochet, Marie-Eva Pickering, Anne Tournadre, Martin Soubrier

Erschienen in: Rheumatology International | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

It is clear that there is an increased cardiovascular (CV) risk in rheumatoid arthritis (RA) as a result of systemic inflammation. Hand osteoarthritis (HOA) patients, also have an increased CV risk, but the causes are still debated. Our objective was to compare CV risk factors and risk scores between HOA and RA patients. Thirty-five HOA patients were matched by age (< 3 years) and sex to 35 RA patients in a case–control study. We compared their CV risk profiles and their risk of occurrence of CV events at 10 years using the risk equations SCORE1, SCORE2, and QRISK3. There was a significant increase in SCORE1, SCORE2, but not in QRISK3 in the RA group compared to the HOA group, provided that the multiplication coefficient for RA was applied. This increase was found to no longer be significant for SCORE1 when RA patients have low disease activity (DAS28 ≤ 3.2; n = 8). There was no difference between groups in the frequency of metabolic syndrome, blood pressure, abdominal circumference, body mass index, uricemia, triglyceridemia, HDL cholesterolemia, or pain intensity. Conversely, HOA patients had higher LDL cholesterol and fasting blood glucose levels, in the main analysis and in the subgroup of moderate/high RA activity patients (DAS28 > 3.2; n = 26). We found a higher CV risk in RA compared to HOA patients with moderate/high disease activity. The increased CV risk reported in OA remains to be confirmed in HOA, but these patients appear to have a pro-atherogenic lipid and glycemic profile.
Literatur
2.
Zurück zum Zitat Symmons D, Gabriel S (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7:399–408PubMedCrossRef Symmons D, Gabriel S (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7:399–408PubMedCrossRef
3.
Zurück zum Zitat Del Rincon I, Williams K, Stern P, Freeman G, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional risk factors. Arthritis Rheum 44:2737–2745PubMedCrossRef Del Rincon I, Williams K, Stern P, Freeman G, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional risk factors. Arthritis Rheum 44:2737–2745PubMedCrossRef
4.
Zurück zum Zitat Bergstra SA, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards CJ et al (2023) Efficacy, duration of use ans safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 82:81–94PubMedCrossRef Bergstra SA, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards CJ et al (2023) Efficacy, duration of use ans safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 82:81–94PubMedCrossRef
5.
Zurück zum Zitat Togo K, Ebata N, Yonemoto N, Abraham L (2022) Safety risk associated with use of nonsteroidal anti‐inflammatory drugs in Japanese elderly compared with younger patients with osteoarthritis and/or chronic low back pain: a retrospective database study. Pain Pract 22:200–209PubMedCrossRef Togo K, Ebata N, Yonemoto N, Abraham L (2022) Safety risk associated with use of nonsteroidal anti‐inflammatory drugs in Japanese elderly compared with younger patients with osteoarthritis and/or chronic low back pain: a retrospective database study. Pain Pract 22:200–209PubMedCrossRef
7.
Zurück zum Zitat Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarth Cartil 21:16–21CrossRef Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarth Cartil 21:16–21CrossRef
8.
Zurück zum Zitat Rahmati M, Mobasheri A, Mozafari M (2016) Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 85:81–90PubMedCrossRef Rahmati M, Mobasheri A, Mozafari M (2016) Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 85:81–90PubMedCrossRef
9.
Zurück zum Zitat Mabasheri A, Saarakkala S, Finnilä M, Karsdal MA, Bay-Jensen AC, van Spil WE (2019) Recent advances in understanding the phenotypes of osteoarthritis. F1000Res 8:F1000 Mabasheri A, Saarakkala S, Finnilä M, Karsdal MA, Bay-Jensen AC, van Spil WE (2019) Recent advances in understanding the phenotypes of osteoarthritis. F1000Res 8:F1000
10.
Zurück zum Zitat Kortekaas M, Kwok WY, Reijnierse M, Huizinga T, Kloppenburg M (2013) In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann Rheum Dis 72:930–934PubMedCrossRef Kortekaas M, Kwok WY, Reijnierse M, Huizinga T, Kloppenburg M (2013) In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann Rheum Dis 72:930–934PubMedCrossRef
11.
Zurück zum Zitat Mathieu S, Couderc M, Tournadre A, Soubrier M (2019) Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine 86:679–684PubMedCrossRef Mathieu S, Couderc M, Tournadre A, Soubrier M (2019) Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine 86:679–684PubMedCrossRef
12.
Zurück zum Zitat Conroy R, Pyörälä K, Fitzgerald A, Sans S, Menotti A, De Backer G et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003PubMedCrossRef Conroy R, Pyörälä K, Fitzgerald A, Sans S, Menotti A, De Backer G et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003PubMedCrossRef
13.
Zurück zum Zitat Hippisley-Cox J, Coupland C, Brindle P (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357:j2099PubMedPubMedCentralCrossRef Hippisley-Cox J, Coupland C, Brindle P (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357:j2099PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat SCORE 2 working group (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42:2439–2454CrossRef SCORE 2 working group (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42:2439–2454CrossRef
15.
Zurück zum Zitat Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRef Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRef
16.
Zurück zum Zitat Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMedCrossRef Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMedCrossRef
17.
Zurück zum Zitat Grundy S, Brewer H Jr, Cleeman J, Smith S Jr, Lenfant C (2004) American Heart Association Definition Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438PubMedCrossRef Grundy S, Brewer H Jr, Cleeman J, Smith S Jr, Lenfant C (2004) American Heart Association Definition Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438PubMedCrossRef
18.
Zurück zum Zitat Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T et al (2016) Cardiovascular risk estimation in older persons: SCORE-OP. Eur J Prev Cardiol 23:1093–1103PubMedCrossRef Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T et al (2016) Cardiovascular risk estimation in older persons: SCORE-OP. Eur J Prev Cardiol 23:1093–1103PubMedCrossRef
19.
Zurück zum Zitat Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28PubMedCrossRef Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28PubMedCrossRef
20.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioural sciences. L. Erbaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioural sciences. L. Erbaum Associates, Hillsdale
21.
Zurück zum Zitat Rodriguez-Vargas G, Santos-Moreno P, Rubio-Rubio J, Bautista-Nino P, Echeverri D, Gutierrez-Castaneda LD et al (2022) Vascular age, metabolic panel, cardiovascular risk and inflaming in patients with rheumatoid arthritis compared with patients with osteoarthritis. Front Cardiovasc Med 9:894577PubMedPubMedCentralCrossRef Rodriguez-Vargas G, Santos-Moreno P, Rubio-Rubio J, Bautista-Nino P, Echeverri D, Gutierrez-Castaneda LD et al (2022) Vascular age, metabolic panel, cardiovascular risk and inflaming in patients with rheumatoid arthritis compared with patients with osteoarthritis. Front Cardiovasc Med 9:894577PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Koutroumpas A, Giannoukas A, Zintzaras E, Exarchou E, Baliakos A, Makaritsis K et al (2013) Erosive hand osteoarthritis is associated with subclinical atherosclerosis and endothelial dysfunction. Int J Biomed Sci 9:217–223PubMedPubMedCentral Koutroumpas A, Giannoukas A, Zintzaras E, Exarchou E, Baliakos A, Makaritsis K et al (2013) Erosive hand osteoarthritis is associated with subclinical atherosclerosis and endothelial dysfunction. Int J Biomed Sci 9:217–223PubMedPubMedCentral
23.
Zurück zum Zitat Venetsanopoulou A, Pelechas E, Voulgari P, Drosos A (2020) The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int 40:1181–1191PubMedCrossRef Venetsanopoulou A, Pelechas E, Voulgari P, Drosos A (2020) The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int 40:1181–1191PubMedCrossRef
24.
Zurück zum Zitat Salamon L, Morovic-Vergles J, Marasovic-Krstulovic D, Kehler T, Sakic D, Badovinac O et al (2015) Differences in prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study. Rheumatol Int 35:2047–2057PubMedCrossRef Salamon L, Morovic-Vergles J, Marasovic-Krstulovic D, Kehler T, Sakic D, Badovinac O et al (2015) Differences in prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study. Rheumatol Int 35:2047–2057PubMedCrossRef
25.
Zurück zum Zitat Johar H, Spieler D, Bidlingmaier M, Herder C, Rathmann W, Koenig W, Peters A et al (2021) Chronic inflammation mediates the association between cortisol and hyperglycemia: findings from the Cross-Sectional Population-Based KORA Age Study. J Clin Med 10:2751PubMedPubMedCentralCrossRef Johar H, Spieler D, Bidlingmaier M, Herder C, Rathmann W, Koenig W, Peters A et al (2021) Chronic inflammation mediates the association between cortisol and hyperglycemia: findings from the Cross-Sectional Population-Based KORA Age Study. J Clin Med 10:2751PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Herder C, Faerch K, Carstensen-Kirberg M, Lowe G, Haapakoski R, Witte D et al (2016) Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. Eur J Endocrinol 175:367–377PubMedCrossRef Herder C, Faerch K, Carstensen-Kirberg M, Lowe G, Haapakoski R, Witte D et al (2016) Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. Eur J Endocrinol 175:367–377PubMedCrossRef
27.
Zurück zum Zitat Mohajer B, Kwee RM, Guermazi A, Berenbaum F, Wan M, Zhen G et al (2021) Syndrome and osteoarthritis disctribution in the hand joints: a propensity score matching analysis from the osteoarthritis initiative. J Rheumatol 48:1608–1615PubMedCrossRef Mohajer B, Kwee RM, Guermazi A, Berenbaum F, Wan M, Zhen G et al (2021) Syndrome and osteoarthritis disctribution in the hand joints: a propensity score matching analysis from the osteoarthritis initiative. J Rheumatol 48:1608–1615PubMedCrossRef
28.
Zurück zum Zitat Liu ST, Zhu WT, Chen BW, Chen YH, Ni GX (2020) Bidirectional association between metabolic syndrome and osteoarthritis: a meta-analysis of observational studies. Diabetol Metab Syndr 7:12–38 Liu ST, Zhu WT, Chen BW, Chen YH, Ni GX (2020) Bidirectional association between metabolic syndrome and osteoarthritis: a meta-analysis of observational studies. Diabetol Metab Syndr 7:12–38
29.
Zurück zum Zitat Klüppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C et al (2015) Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study. Diabetologica 58:2269–2277CrossRef Klüppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C et al (2015) Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study. Diabetologica 58:2269–2277CrossRef
30.
Zurück zum Zitat Marshall M, Peat G, Nicholls E, Myers H, Mamas M, van der Windt DA (2019) Metabolic risk factors and the incidence and progression of radiographic hand osteoarthritis: a population-based cohort study. Scand J Rheumatol 48:52–63PubMedCrossRef Marshall M, Peat G, Nicholls E, Myers H, Mamas M, van der Windt DA (2019) Metabolic risk factors and the incidence and progression of radiographic hand osteoarthritis: a population-based cohort study. Scand J Rheumatol 48:52–63PubMedCrossRef
31.
Zurück zum Zitat Mohajer B, Kwee RM, Guermazi A, Berenbaum F, Wan M, Zhen G et al (2021) Metabolic syndrome and osteoarthritis distribution in the hand joints: a propensity score matching analysis from the Osteoarthritis Initiative. J Rheumatol 48:1608–1615PubMedCrossRef Mohajer B, Kwee RM, Guermazi A, Berenbaum F, Wan M, Zhen G et al (2021) Metabolic syndrome and osteoarthritis distribution in the hand joints: a propensity score matching analysis from the Osteoarthritis Initiative. J Rheumatol 48:1608–1615PubMedCrossRef
32.
Zurück zum Zitat Del Rincon I, Battafarano D, Restrepo J, Erikson J, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66:264–272PubMedCrossRef Del Rincon I, Battafarano D, Restrepo J, Erikson J, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66:264–272PubMedCrossRef
33.
Zurück zum Zitat Gorter SL, Bijlsma J, Cutolo M, Gomez-Reino J, Kouloumas M, Smolen J et al (2010) Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:1010–1014PubMedCrossRef Gorter SL, Bijlsma J, Cutolo M, Gomez-Reino J, Kouloumas M, Smolen J et al (2010) Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:1010–1014PubMedCrossRef
34.
Zurück zum Zitat Ocon AJ, Reed G, Pappas D, Curtis J, Kremer J (2021) Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ann Rheum Dis 80:1522–1529PubMedCrossRef Ocon AJ, Reed G, Pappas D, Curtis J, Kremer J (2021) Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ann Rheum Dis 80:1522–1529PubMedCrossRef
35.
Zurück zum Zitat Minhas D, Nidhaan A, Husni M (2023) Recommendations for the use of nonsteroidal anti-inflammatory drugs and cardiovascular disease risk: decades later, and new lessons learned? Rheum Dis Clin N Am 49:179–191CrossRef Minhas D, Nidhaan A, Husni M (2023) Recommendations for the use of nonsteroidal anti-inflammatory drugs and cardiovascular disease risk: decades later, and new lessons learned? Rheum Dis Clin N Am 49:179–191CrossRef
36.
Zurück zum Zitat Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480–489PubMedCrossRef Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480–489PubMedCrossRef
37.
Zurück zum Zitat Mathieu S, Pereira B, Tournadre A, Soubrier M (2018) Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis. Ann Rheum Dis 77:e65PubMedCrossRef Mathieu S, Pereira B, Tournadre A, Soubrier M (2018) Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis. Ann Rheum Dis 77:e65PubMedCrossRef
38.
Zurück zum Zitat Atzeni F, Rodriguez-Carrio J, Popa C, Nurmohamed M, Szucs G, Szekanecz Z (2021) Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat Rev Rheumatol 17:270–290PubMedCrossRef Atzeni F, Rodriguez-Carrio J, Popa C, Nurmohamed M, Szucs G, Szekanecz Z (2021) Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat Rev Rheumatol 17:270–290PubMedCrossRef
39.
Zurück zum Zitat Mathieu S, Tournadre A, Soubrier M, Sellam J (2022) Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: a meta-analysis. Jt Bone Spine 89:105444CrossRef Mathieu S, Tournadre A, Soubrier M, Sellam J (2022) Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: a meta-analysis. Jt Bone Spine 89:105444CrossRef
40.
Zurück zum Zitat Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V et al (2021) Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum 51:831–838PubMedCrossRef Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V et al (2021) Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum 51:831–838PubMedCrossRef
41.
Zurück zum Zitat Kedor C, Detert J, Rau R, Wassenberg S, Listing J, Klaus P, Braun T et al (2021) Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open 7:e001660PubMedPubMedCentralCrossRef Kedor C, Detert J, Rau R, Wassenberg S, Listing J, Klaus P, Braun T et al (2021) Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open 7:e001660PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Aitken D, Laslett L, Pan F, Haugen I, Otahal P, Bellamy N et al (2018) A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis- the HUMOR trial. Osteoarth Cartil 26:880–887CrossRef Aitken D, Laslett L, Pan F, Haugen I, Otahal P, Bellamy N et al (2018) A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis- the HUMOR trial. Osteoarth Cartil 26:880–887CrossRef
43.
Zurück zum Zitat Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M et al (2019) Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Jt Bone Spine. 86:135–150CrossRef Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M et al (2019) Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Jt Bone Spine. 86:135–150CrossRef
44.
Zurück zum Zitat Kloppenburg M, Kroon F, Blanco F, Doherty M, Dziedzic K, Greibrokk E et al (2019) 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis 78:16–24PubMedCrossRef Kloppenburg M, Kroon F, Blanco F, Doherty M, Dziedzic K, Greibrokk E et al (2019) 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis 78:16–24PubMedCrossRef
Metadaten
Titel
Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients
verfasst von
Sylvain Mathieu
C. Lambert
Françoise Fayet
Marion Couderc
Marine Beauger
Sandrine Malochet
Marie-Eva Pickering
Anne Tournadre
Martin Soubrier
Publikationsdatum
11.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2023
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05405-3

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Leitlinienkonformes Management thermischer Verletzungen

Thermische Verletzungen gehören zu den schwerwiegendsten Traumen und hinterlassen oft langfristige körperliche und psychische Spuren. Die aktuelle S2k-Leitlinie „Behandlung thermischer Verletzungen im Kindesalter (Verbrennung, Verbrühung)“ bietet eine strukturierte Übersicht über das empfohlene Vorgehen.

Verschlechtert frühe Hyperoxie nach Reanimation die Prognose?

Kommt es sehr früh nach einer kardiopulmonalen Reanimation zu einem Zustand der Hyperoxie, ist dies bei Patienten nach einem Herzstillstand mit schlechteren funktionellen Ergebnissen assoziiert. Das zeigt eine Sekundäranalyse der TTM-2-Studie.

Infektanfälligkeit in früher Kindheit: eine bleibende Last?

Wenn Kinder in den ersten Lebensjahren immer wieder Infekte durchmachen, lässt dies Schlüsse auf die Infektneigung in der weiteren Kindheit zu.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.